background: Bisphenol A (BPA) is a 'weak' endocrine disruptor. The effect of BPA on human reproduction is controversial but has been related to meiotic anomalies, recurrent miscarriages and abnormal karyotypes.
Introduction
Bisphenol A [BPA; 2, 2-bis (4-hydroxyphenyl) propane; CAS# 80-05-7] is one of the highest-volume chemical products produced worldwide (Vandenberg et al., 2007) . This compound is a plastic monomer and a plasticizer used in the production of polycarbonate plastics and epoxy resins found in metal cans and many other plastic products such as toys, water pipes, drink containers, food packing, eyeglass lenses, sport safety equipment, dental sealants and medical equipment (Vandenberg et al., 2009 (Vandenberg et al., , 2010a . Human exposure to BPA may occur by workplace-related inhalation during its production (Vandenberg et al., 2010b) , but the most common way of exposure is oral intake, derived from migration of the compound from canned beverages, foods and baby bottles (Biles et al., 1999; Imanaka et al., 2001; Goodson et al., 2004; Guobing et al., 2005; Onn Wong et al., 2005; Wetherill et al., 2007; Chapin et al., 2008; Willhite et al., 2008) .
BPA is considered an endocrine disruptor with a 'weak' estrogenic effect. Biochemical assays have determined that BPA binds to both estrogen receptors, alpha (ERa) and beta (ERb), with an approximately 10-fold higher affinity to ERb (Kuiper et al., 1998; Pennie et al., 1998) . At the same time, BPA binds strongly to the cellmembrane receptors and estrogen-related receptor g (ERRg) (Horard and Vanacker 2003; Okada et al., 2008) .
Studies of the possible reproductive health effects of BPA on humans are limited, but they have associated BPA exposure with obesity, endometrial hyperplasia, recurrent miscarriages, abnormal karyotypes and polycystic ovarian syndrome (Takeuchi and Tsutsumi, 2002; Takeuchi et al., 2004; Sugiura-Ogasawara et al., 2005; Yang et al., 2006) .
Around 20 -24 weeks of gestation, the maximal population of oocytes at the ovary is observed (6.8 million). Around the 11 -13th weeks of gestation, oocytes initiate meiosis (Baker, 1963) . Meiosis is the special cell division characterized by the reductional division of the genome, generating haploid cells after two successive cell divisions following one round of DNA replication. In females, this process begins in utero and concludes only if the oocyte is fertilized. During the fetal period, the first meiotic prophase occurs and from there oocytes remain arrested at dictyonema for years or decades. During the meiotic prophase, pairing-synapsis and recombination of homologous chromosomes occur. Double-strand breaks are generated along the genome, which initiates those processes. These breaks are repaired by homologous recombination either as crossovers (COs, when the double-strand breaks (DSB)-flanking regions are exchanged between the homologs) or as non-COs (when no exchange happens between the homologs). Cytologically CO can be visualized by the deposition of the mismatch repair protein MLH1 (See review, Hoffmann and Borts, 2004) .
The effect of BPA on mammalian oocytes can be analyzed at early stages of meiosis (those stages that occur in utero) and late stages (conclusion of first and second meiotic division, post-puberty). Effects of BPA on late-stage oocytes are: In vitro exposed cumulus-enclosed mouse oocytes showed a dose-response retardation to reach metaphase I, telophase I arrest, elongation of the spindle, dispersion of pericentriolar material at metaphase II (MII) and chromosome failure to congress at spindle and incapacity to resume meiosis. Mouse oocytes exposed in vitro or during fetal development to BPA fail to properly align chromosomes at the spindle equator at MII, present unbalanced chromosome sets and conceptions. BPA-exposed oocytes are more prone to miscarriage than non-exposed oocytes (Hunt et al., 2003; Can et al., 2005; Eichenlaub-Ritter et al., 2008; Lenie et al., 2008; Mlynarcikova et al., 2009) . However, little is known about BPAs effect on early oocytes (Susiarjo et al., 2007; Hunt et al., 2009) . Studies conducted on mouse fetal oocytes have concluded that BPA affects synapsis and meiotic recombination. BPA-exposed oocytes showed synaptic defects such as end-to-end chromosome associations and incomplete synapsis (Susiarjo et al., 2007; Hunt et al., 2009) . Moreover, these oocytes also showed increased levels of the total MLH1 foci and chiasmata. The increments of the MLH1 foci number and chiasmata seem to be related to ERb, since in ERb knockout oocytes, recombination mimics the alterations observed in BPA-exposed animals (Susiarjo et al., 2007; Hunt et al., 2009) . Therefore, the authors suggested that BPA acts as an ERb antagonist.
A more recently study performed in Caenorhabditis elegans (C. elegans) shows that BPA induces sterility, reducing the number of viable oocytes and increasing embryo lethality as well as impairing chromosome synapsis and disruption of double-strand breaks repair progression. The authors have also described that BPA exposure results in impaired chromosome segregation during metaphase (Allard and Colaiacovo, 2010) .
The main objective of this in vitro study was to evaluate the possible effects of BPA on meiotic prophase in human fetal oocytes from cultured ovaries for the first time. Estradiol (E 2 ) was used as positive control of ER activity. Survival and meiotic progression were evaluated following the number of degenerated oocytes and the percentage of oocytes found in each sub-stage of meiotic prophase respectively. Immunofluorescence (IF) against lateral element protein 3 (SYCP3), central element protein (SYCP1) of synaptonemal complex and cohesin REC8 was performed to evaluate pairing and synapsis. Meiotic recombination was analyzed by IF following mismatch repair protein MLH1, used as a CO marker.
Materials and Methods

Biological material
Twelve ovaries were obtained from the Vall d'Hebron Fetal Tissue Bank, following the rules of the Ethical Committee of the Hospital de la Vall d'Hebron, Barcelona, Spain. Last menstrual period, ultrasound analysis and foot length were used to calculate gestational age. Inclusion criteria were: euploid fetuses [confirmed in the laboratory with the karyotype of cultured fetal ovary stroma (Roig et al., 2003) ], gestational age between 18 and 22 weeks, ,2 h from the end of the obstetric procedure and the start of the culture process. Cases used are shown in Table I .
Culture conditions
Ovaries were cultured following the fetal human oocytes culture technique described elsewhere (experimental design shown in Fig. 1 McIwain Tissue Chopper (Jed Pella Inc., Redding, CA, USA) into miniblocks of 1 mm × 1 mm × 1 mm. Then mini-blocks were re-suspended in culture medium. Five mini-blocks were taken at random from main pool and were seeded in a 24-well cell-culture cluster (Costar, Corning Inc., NY, USA). Control medium used was: Dulbecco's modified Eagle's medium (Gibco BLR) supplemented with 5 mg/ml insulin, 5 mg/ml transferrin, 5 ng/ml selenium, 100 ng/ml stem cell factor (SCF) (all from Sigma, Munich, Germany), 100 UI/ml penicillin and 100 mg/ml streptomycin (both from Gibco BRL). The mini-blocks were seeded and cultured for 7 (T7), 14 (T14) or 21 days (T21) at 378C, 5% CO 2 .
BPA and E 2 , were dissolved in 0.01% dimethyl sulfoxide (DMSO; all from Sigma). A live/dead cell double-staining kit (Sigma) was used to obtain the optimal concentration of DMSO (data not shown).
Twelve different culture conditions were studied. Control group: ovarian mini-blocks cultured with control medium. DMSO-supplemented medium: To test the influence of DMSO on oocytes, ovarian mini-blocks were cultured with control medium + 0.01% DMSO. BPA-supplemented medium: Five different concentrations of BPA were added to control medium: 1, 5, 10, 20 and 30 mM BPA. The concentration range was chosen according to Environmental Protection Agency (EPA) and UE legislation as well as concentrations used in previous reports. E 2 -supplemented medium: b-E 2 was selected as a positive control of steroid hormone action. Five BPA equipotent concentrations of E 2 were added to control medium (1, 5, 10, 20 and 30 nM E 2 ). DMSO concentration never exceeded 0.01% in those ovarian mini-blocks cultured with BPAsupplemented medium and E 2 -supplemented medium. Every 2 days, 50% of the culture medium was changed for fresh medium. Ovarian mini- Figure 1 Diagram of the experimental design experimental protocol followed to culture each sample (for more details, see at Supporting Materials and Methods). Control: oocytes from ovaries cultured with non-supplemented medium. DMSO: oocytes from ovaries cultured with DMSOsupplemented medium as negative control. BPA 1 mM: oocytes from ovaries cultured with 1 mM BPA-supplemented medium. BPA 5 mM: oocytes from ovaries cultured with 5 mM BPA-supplemented medium. BPA 10 mM: oocytes from ovaries cultured with 10 mM BPA-supplemented medium. BPA 20 mM: oocytes from ovaries cultured with 20 mM BPA-supplemented medium. BPA 30 mM: oocytes ovaries cultured with 30 mM BPA-supplemented medium. E 2 1 nM: oocytes from ovaries cultured with 1 nM E 2 -supplemented medium. E 2 5 nM: oocytes from ovaries cultured with 5 nM E 2 -supplemented medium. E 2 10 nM: oocytes from ovaries cultured with 10 nM E 2 -supplemented medium. E 2 20 nM: oocytes from ovaries cultured with 20 nM E 2 -supplemented medium. E 2 30 nM: oocytes from ovaries cultured with 30 nM E 2 -supplemented medium, all of them as a positive control. T7: 7 days after culture. T14: 14 days after culture. T21: 21 days after culture. blocks were removed from the wells as described elsewhere (Brieño-Enriquez et al., 2010) .
Oocyte spread preparation
Oocyte spread preparations were performed as described elsewhere (Brieño-Enriquez et al., 2010) . Briefly, the pellet was re-suspended in 1.5 ml of phosphate-buffered saline (PBS). Over slides and in a cytocentrifuge chamber, 20 ml of cell suspension and 500 ml of 0.02 M sucrose solution were added and cyto-centrifuged for 15 min at 115g. After that, the slides were placed in a humid chamber at room temperature for 2 h and then fixed with formaldehyde (9%, pH 10). After 24 h at room temperature, slides were washed with 1% PhotoFlo (Kodak, Paris, France) four times and air-dried; slides were kept at 2808C until analyzed.
Immunofluorescence IF against proteins of SYCP3 and SYCP1 of the synaptonemal complex (Abcam plc; Cambridge, UK), cohesin REC8, and mismatch repair protein MLH1 (BD Pharmigen, Becton Dickinson France S.A.S.; Erembodegem, Belgium) was performed as described elsewhere (Brieño-Enriquez et al., 2010) . Briefly, after the fixation process, the oocyte spreads were treated with 0.1% Triton-X (Sigma) in PBS for 45 min. Primary antibodies were diluted (1:100) in blocking solution and incubated 24 h at 48C in a humid chamber. Unbound antibodies were removed by washing with PBS, and detection was carried out with goat anti-rabbit FITC, goat antirabbit Cy3, goat anti-mouse Cy3, goat anti-mouse FITC (Jackson ImmunoResearch Laboratories, West Grove, PA, USA); all of them were diluted (1:100) in blocking solution. Secondary antibodies were incubated 1 h at 378C in a humid chamber. Unbound secondary antibodies were removed by washing with PBS, and the signal was fixed with 1% formaldehyde. DNA was counterstained by applying antifade solution (Vector laboratories, Burligame, CA, USA) containing 0.1 mg/ml of DAPI 4(6-diamidino-2-phenylindole; Sigma).
Oocytes were sub-staged according to morphological criteria described in previous studies (Supplementary data, Fig. S1 ) (Garcia et al., 1987; Roig et al., 2003 Roig et al., , 2006 Brieño-Enriquez et al., 2010) . As was described previously, at leptonema, chromosomes start condensation, and the lateral elements of synaptonemal complex (SYCP2 and SYCP3) are assembled over a cohesin scaffold (REC8). During zygonema, the SYCP1 protein creates a zipper-like structure between both pairs of sister chromatids to complete synapsis (Eijpe et al., 2003; Ghafari et al., 2007; Yang and Wang, 2009) . Finally, at pachynema, bivalents are fully paired and all of the elements look like one single structure. As was previously reported by Roig et al. (2006) , oocytes in culture could degenerate and this process is especially higher in oocytes at pachynema. The evaluation of these oocytes was performed by the contraction and deformation of nuclei in the presence of SYCP3 and SYCP1 protein (Roig et al., 2006) .
Chromosome 21 fish
A chromosome-21-specific probe (LPT21QG21 probe, from Aquarius probes, Cytocell, Cambridge, UK) was used for the identification of chromosome 21. The probe was hybridized on previously immunostained preparations. Briefly, slides were washed with 2 × saline sodium citrate (SSC) pH 7.0 for 2 min, after which they were dehydrated in an ethanol series (70, 85 and 100%), each one for 2 min and dried at room temperature. Immediately, thereafter, 10 ml of probe solution was added to the sample and the slide covered with a coverslip. Denaturization of the sample and probe was performed simultaneously by heating a hotplate at 758C for 2 min. Hybridization was performed in a humid lightproof container at 378C overnight. After hybridization, the slides were washed in 0.4 × SSC (pH 7.0) at 728C for 2 min followed by a second wash with 2 × SSC + 0.05% Tween 20, at room temperature for 30 s. Finally, DNA was counterstained by applying antifade solution containing 0.1 mg/ml of DAPI (Sigma).
Image analysis and statistics
All samples were analyzed using an Olympus B × 70 fluorescence microscope (Olympus Optical Co, Hamburg, Germany). Images were captured and produced using Smart Capture software. To match the fluorescence intensity that was observed by microscope, images were processed using Adobe Photoshop. Statistical analysis among sample repeat and inter-sample repeat was performed using U Mann-Whitney. Two-way analysis of variance followed by the Bonferroni post-test was applied to compare control oocytes with treated oocytes. The MLH1 mean foci number distribution in chromosome 21 was evaluated using the Kruskal -Wallis test. Statistical significance for variables in all tests was set at ≤0.05.
Results
A total of 21 510 oocytes from 12 cultured ovaries were analyzed: 17 105 oocytes to evaluate the effects on meiotic progression and survival of the oocytes, and 4405 for meiotic recombination. Oocytes at meiotic prophase were found at all culture times in all biological samples used (Supplementary data, Table SI ). To evaluate pairingsynapsis, two different slides for culture time and culture medium were used, and an independent slide was used for meiotic recombination analysis (Fig. 1) . No statistical differences in any sample (P ¼ 0.55) or inter-sample repeat (P ¼ 0.78) were found.
BPA decreases oocyte survival
Firstly, the effect of BPA on the survival of oocytes from cultured ovaries was evaluated. Oocyte survival was evaluated according to the number of degenerated oocytes found for each culture condition. Table SII ). Nevertheless, a significant increase of 2.6% of degenerated oocytes was observed at T21 in cultures treated with DMSO-supplemented medium (P ¼ 0.01).
Ovaries cultured with BPA, independently of the concentration applied, showed an increment of degenerated oocytes from 3.1 to 15.0%, when compared with control at T7 (P ¼ 0.001), at T14, from 4.9 to 19.9% and from 6.6 to 27.0% at T21, all of them being significantly different (P ¼ 0.001) ( Fig. 2A and Supplementary data, Table SII ).
For ovaries cultured with E 2 -supplemented medium, reduction of cell viability was observed in all of the concentrations applied. The increment of degenerated oocytes varied from 2.3 to 14.0% more than for the control at T7; at T14, it went from 3.9 to 19.6% and at T21 the increment rose from 5.7 to 27.1%, all of them with statistical differences, when compared with control (P ¼ 0.001) (Fig. 2A,  Supplementary data, Fig. SII and Supplementary data, Table SII ).
BPA disrupts meiotic progression
Previous studies performed on mice and C. elegans have suggested that BPA could affect the evolution of synapsis (Susiarjo et al., 2007; Hunt et al., 2009; Allard and Colaiacovo, 2010) ; so it was decided to monitor it, using IF against proteins REC8, SYCP3 and SYCP1. The pairing-synapsis was evaluated following the correct alignment and synapsis of the homolog chromosomes along the different culture times (Supplementary data, Fig. SI Table   SV ). Degenerated oocytes were not included in order to calculate the percentages of the sub-stages. Different levels of meiotic progression were found among the different media used.
Ovaries cultured with DMSO-supplemented medium did not show any changes in the percentage of oocytes at leptonema, when compared with control at any of the culture times (P ≥ 0.05) (Supplementary data, Fig. SIII and Supplementary data, Table SIII ). Oocytes from ovaries cultured with BPA-supplemented medium showed a nonsignificant increase at T7 (P ≥ 0.05). At T14, ovaries cultured with concentrations equal to (or higher than) 10 mM BPA showed a significant increment, going from 6.0 to 12.3% oocytes at leptonema (P ≤ 0.05). In contrast, at T21 significant increments of oocytes at leptonema were observed, even with the lowest concentrations (1 mM). Increments of oocytes at leptonema at T21 varied from 5.6 to 22.4% more oocytes than did the control (P ¼ 0.01) (Fig. 2B , Supplementary data, Fig. SIII and Supplementary data, Table SIII) .
At T7 and T14, oocytes from ovaries cultured with E 2 -supplemented medium showed an increment of oocytes at leptonema without statistical differences (P ≥ 0.05). At T21, a significant increment of oocytes at leptonema was observed for all E 2 concentrations used. The range of increment observed was from 4.6 to 9.3% (P ≤ 0.05) (Fig. 2B, Supplementary data, Fig. SIII and Supplementary data, Table SIII ).
The percentage of oocytes at zygonema from cultured ovaries did not show significant differences among control and the rest of the culture media used (Supplementary data, Fig. SIV and Supplementary data, Table SIV; P ≥ 0.05).
A significant reduction of the percentage of oocytes at pachynema was observed with all of the concentrations of BPA used and culture times (Fig. 2C, Supplementary data, Fig. SV and Supplementary data, Table SV ). At T7, the reduction of the percentage of oocytes at pachynema went from 3.2 to 5.2%, at T14 it rose from 6.7 to 14.3% and at T21 it went from 6.5 to 19.8%, all differences being statistically significant (all of them P ≤ 0.01) (Fig. 2C, Supplementary data, Fig. SV and Supplementary data, Table SV) .
Ovaries cultured with E 2 -supplemented medium showed a nonsignificant decrease in the percentage of pachynema oocytes at T7 (P ≥ 0.05), statistical differences only being observed in those treated with E 2 5 nM (P ¼ 0.01). Cultures at T14 and T21 showed a significant reduction in the percentage of oocytes at pachynema for all of the concentrations of E 2 -supplemented medium, when compared with controls (P ¼ 0.01) (Fig. 2C, Supplementary data, Fig. SV and Supplementary data, Table SV ).
BPA increases the number of MLH1 foci
Because BPA exposure to mice causes a significant increase in the number of MHL1 foci and chiasmata (Susiarjo et al., 2007; Hunt et al., 2009) , its effects were analyzed on cultured human fetal oocytes. Meiotic recombination was analyzed following the number of MLH1 foci at pachynema (Fig. 3A, Fig. 4 and Supplementary data, Fig. SVI) . All of the oocytes at pachynema, independently of the medium used, showed MLH1 protein foci (CO markers) (Supplementary data, The means, as well as the ranges, of MLH1 foci found on fresh oocytes, oocytes from ovaries cultured with control medium and DMSO-supplemented medium were not significantly different (P ≥ 0.05). At T7, oocytes from ovaries cultured with 10, 20 and 30 mM BPA showed an increment of the mean MLH1 foci number of 40.3, 54.8 and 65.5% more than did the control at T7 (P ¼ 0.01). At T14, oocytes from ovaries treated with 10, 20 and 30 BPA showed an increment of their MLH1 foci number of 39.2, 53.3 and 60.4% more than did the control (P ≤ 0.05). The increment of MLH1 foci at T21 showed the same trend. In these oocytes, the mean foci number showed a significant increment of 40.3% (10 mM BPA), 52.9% (20 mM BPA) and 62.0% (30 mM BPA), when compared with controls (P ¼ 0.01) (Fig. 3A, Fig. 4 and Table II) .
Oocytes from ovaries cultured with E 2 -supplemented media also showed an increase in the mean MLH1 foci number, related to E 2 concentration and culture time. At T7, there were no statistical differences, when compared with control (P ≥ 0.05). A threshold of increment of MLH1 foci was observed at T14 in oocytes treated with 20 and 30 nM E 2 . Oocytes from ovarian fragments treated with 20 and 30 nM E 2 showed a significant increase in 25.9 and 38.4% more MLH1 foci than in those of controls (P ¼ 0.01). Finally, at T21, a significant increment of the MLH1 mean foci number was also observed in oocytes treated with 10 nM E 2 (P ¼ 0.01) (Fig. 3A  Fig. 4 and Table II) .
Chromosome 21 is one of the most common chromosomes involved in aneuploidies. Thus, we decided to evaluate the effect of BPA on this chromosome by performing an IF against MLH1 followed by a chromosome 21-specific fluorescence in situ hybridization. Ninety oocytes pooled from cultures treated with either 20 or 30 mM BPA at T7 were analyzed (no statistical differences were observed among them.). Bivalents 21 from BPA-exposed oocytes showed a mean MLH1 foci number of 2.2, with a range of 1 -5. Values observed in oocytes from ovaries treated with BPA had two times more MLH1 foci than did those reported in fresh and cultured oocytes (Fig. 3B , Fig. 4 and Supplementary data, Table SVII) (Brieño-Enriquez et al., 2010) . An elevated MLH1 foci number could certainly increase the possibilities of non-disjunction and thus lead to chromosome 21 aneuploidy.
Discussion
This work shows the effect of BPA on human oocytes obtained from cultured fetal ovaries. A great debate concerning the effects of BPA and the safety of human exposure is on the table of scientists, agencies and expert panels. The US EPA and European Food Safety Authority have calculated the reference dose of 0.05 mg/kg body-weight per day (EPA) and 0.06 mg/kg body-weight per day (Vandenberg et al., 2007) . However, detected values could be modified by age, gender, ethnic group, occupation and education (Vandenberg et al., 2009 (Vandenberg et al., , 2010a . In this sense, detected values of BPA in pregnant women and fetuses have been reported to be the double of the values described in healthy adults (Vandenberg et al., 2009 (Vandenberg et al., , 2010b .
Oocyte survival is altered in cultured human fetal ovaries after BPA exposure BPA and E 2 negatively affect oocyte survival in vitro. We did not observe a threshold concentration for the drop off of effects for either of the compounds, implying that, if it exists, it is at a lower concentration than the ones used in the present study. Results obtained indicate that BPA allows for a lower number of oocytes to reach pachynema with a higher percentage of degenerated oocytes in culture, when compared with control samples. A similar effect was observed for equipotent concentrations of E 2 . BPA has been implicated in promoting apoptosis, for example in mouse Sertoli cells (Raychoudhury et al., 1999) and embryos (Richter et al., 2007) , and increases apoptosis in a dose-dependent manner in murine ovarian granulosa cells (Xu et al., 2002; Mlynarcikova et al., 2005) . Activity of BPA in models of acute myeloid leukemia indicates that it is able to induce cell-cycle arrest and caspase-dependent apoptosis beyond the endocrinal disruptor activity (Bontempo et al., 2009) . The induction of these apoptotic pathways in fetal oocytes could explain the high index of degenerated oocytes found in culture. Because oocytes cultured with E 2 -supplemented medium also showed an increment in the percentages of degenerated oocytes, we hypothesize that the BPA pro-degenerative effect observed in vitro might be related to a tissue-specific, estrogenic receptor-related function (Hiroi et al., 1999; Lund et al., 1999; Takayanagi et al., 2006; Miller et al., 2007; Symonds et al., 2008) . Nevertheless, it is still possible that both substances may act on different pathways, leading to the same effect.
Human fetal oocytes from cultured ovaries exposed to BPA showed a delayed meiotic progression in vitro
We described the effect of BPA and E 2 on meiotic prophase progression in oocytes from cultured ovaries. This effect was related to variations of the percentage of oocytes at different sub-stages. The effects of BPA on oocytes from cultured ovaries showed a different pattern depending on the sub-stage analyzed.
There was an increment in the percentage of oocytes at leptonema in relation to culture time and BPA concentration. This phenomenon could be explained, firstly, by the entrance into meiosis of some oogonia as well as an activation of anti-apototic pathways in the oocytes by SCF added to culture medium (Pesce et al., 1993; Thomas and Vanderhyden, 2006; Zeuner et al., 2007) . In this sense, SCF could affect the mitotic division of oogonia and induce the entry of oogonias into meiosis (Abir et al., 2004; Mlynarcikova et al., 2005; Thomas and Vanderhyden, 2006; . Secondly, another reason could be related to a possible delay in cell-cycle progression. Cell-cycle delay could induce the inability to reach the next sub-stage, in this way inducing an accumulation of oocytes at leptonema, as was observed in C. elegans oocytes (Allard and Colaiacovo, 2010) and mammalian cells at late stages of meiosis (Hunt et al., 2003; Can et al., 2005; Eichenlaub-Ritter et al., 2008; Lenie et al., 2008; Mlynarcikova et al., 2009) . The balance of oocytes at zygonema, as occurs in vivo, was not informative enough to draw any conclusions.
The number of oocytes that reached pachynema was lower in oocytes from cultured ovaries with BPA-supplemented medium. Previous reports in C. elegans and mouse described synaptic defects after exposure of fetal oocytes to BPA (Hunt et al., 2003; Susiarjo et al., 2007; Allard and Colaiacovo, 2010) . Thus, this reduction of oocytes at pachynema could be related to an increase in asynapsis, which in turn could induce retardation or the blocking of the meiotic prophase. Surprisingly, the percentage of degenerated oocytes increased in a proportional manner as the cells at pachynema disappeared. This correlation could suggest that cells at pachynema could be selectively eliminated. However, this idea contradicts the current knowledge of how meiotic checkpoints control female meiosis.
In summary, BPA affects meiotic progression by increasing the percentages of oocytes at leptonema and reducing the percentage of oocytes that reach pachynema in vitro, independently of the concentration used. We cannot establish a threshold for BPA activity in relation to meiotic progression; in other words, all BPA concentrations tested in this study resulted in an effect on meiotic progression. E 2 also showed an alteration in meiotic progression characterized by an increment of oocytes at leptonema and a diminution of pachynema oocytes, but E 2 apparently acts in dose-response time-fashion-like activity. Human fetal oocytes from BPA cultured ovaries showed an altered number of MLH1 foci
The results described herein reveal the effect of BPA also on human meiotic recombination occurring in vitro. Meiotic recombination provides a structural basis for the correct segregation of chromosomes (Bugge et al., 2007; Hassold et al., 2007; Oliver et al., 2008; Cheng et al., 2009; Hassold and Hunt 2009 ). In almost all species, during meiotic recombination, exchanges between the homologous chromosomes result in at least one CO per chromosome arm (Petronczki et al., 2003; Bannister and Schimenti, 2004) . In this study, MLH1 was used as a marker to detect CO in human oocytes. Human fetal oocytes from ovaries cultured with BPA concentrations of 10 mM or higher showed an elevated MLH1 mean foci number, when compared with fresh oocytes or oocytes from ovaries cultured with control medium. The mean MLH1 foci number of BPA-exposed oocytes was affected by BPA concentration. A threshold of the BPA effect on MLH1 foci number was observed at concentrations of 10 mM BPA. Ovaries cultured with E 2 show a dose-response time fashionlike activity. Previous studies revealed the effect of BPA on meiotic recombination in female mice (Hunt et al., 2003; Susiarjo et al., 2007; Susiarjo and Hunt, 2008; Hunt et al., 2009) . Susiarjo et al., (2007) described that ERb knock-out mice had similar recombination defects as did BPA-exposed oocytes, suggesting that BPA acts in fetal ovaries by antagonizing the cellular responses of ERb (Susiarjo et al., 2007) . In this sense, our results showed an increase in MLH1 foci in oocytes treated with BPA as well as in oocytes treated with E 2 , with some important differences: First, oocytes treated with BPA showed a greater number of MLH1 foci than did oocytes treated with equipotent concentrations of E 2 . Second, oocytes treated with BPA showed an increase in MLH1 foci at early stages of culture. Our results are in agreement with the results of Susiarjo et al. (2007) , showing that BPA increases MLH1 foci number formation in mammalian oocytes (Susiarjo et al., 2007) . In this sense, Allard and Colaiácovo (2010) recently have described an alteration of double-strand breaks repair after the exposure of C. elegans to BPA. Data provided in both studies (Susiarjo et al., 2007; Allard and Colaiacovo, 2010) suggest that BPA could act as an ERb antagonist. So, if BPA acts as an ERb antagonist, (Susiarjo et al., 2007; Allard and Colaiacovo, 2010) why did oocytes from E 2 -treated ovaries show a similar effect? One interpretation could be that the observed effect caused by BPA exposure was associated with the balance between ERa and ERb induction. ERa and ERb are present in the fetal ovary. But, during early development, more ERb than ERa is present, until the 20th week of gestation, when the presence of ERa substantially increases (Vaskivuo et al., 2005) . In physiological conditions, E 2 preferentially binds to ERb in the ovary. Therefore, estrogenic effects in the ovary should be related to ERb activation. So, when BPA is present and blocks ERb, the balance between the estrogenic receptors is altered and the effects of ERa could be detectable. Therefore the 'BPA effect' would be related to ERa activation. When high doses of E 2 are applied, the activation of ERa plus the physiological ERb activation would be possible; therefore similar (but not identical) effects of BPA could be seen. Thus, under this interpretation, the BPA effect would cause a cellular response, a consequence of the imbalance between estrogenic receptors ERa and ERb.
The second way of interpreting our data and relating them to those published would be to relate the observed effect to ERRs. ERRs are a sub-family of receptors close to estrogenic receptors ERa and ERb (Chapin et al., 2008) . BPA is considered to be a ligand to these receptors, but the activation of them by E 2 is controversial (Greschik et al., 2002; Horard and Vanacker 2003; Mlynarcikova et al., 2005; Alonso et al., 2006; Okada et al., 2008; Kuiper et al., 1998; Pennie et al., 1998) . It is formally possible that E 2 could act through the activation of ERRs, altering the balance of estrogenic receptor activation, in this way leading to the observed effect on meiocytes. Thus, we cannot exclude that observed effects could be related by ERR activation.
Nevertheless, the average MLH1 foci increment caused by BPA exposure in human oocytes is significantly higher than the one reported in mouse (Hunt et al., 2003; Susiarjo et al., 2007) . It is likely that the different technical approaches used to expose BPA to the animals/cells may have affected these experiments, but it is also likely possible that BPA and E 2 have direct genotoxic effect. Iso et al. (2006) observed the induction of double-strand breaks in human breast adenocarcinoma cell line after exposure to BPA and E 2 (Iso et al., 2006) . Exposed cells displayed an increase in DSB markers, such as gH2AX, which co-localized with other DNA repair proteins, such as Bloom helicase (Iso et al., 2007) . On the other hand, Miyamoto et al. (2006) described that E 2 up-regulated the mismatch repair activity in endometrial cells. Up-regulation of the MLH1 protein in these cells could be related to an increase in cell division and DNA damage (Miyamoto et al., 2006) . Therefore, it is possible that some of the effect of BPA on human oocytes could be related to its genotoxic activity.
In summary, the data obtained in the present study can be interpreted using the existing model based on the mouse and C. elegans data in which BPA is supposed to act as an ERb antagonist (Hunt et al., 2003; Susiarjo et al., 2007; Hunt et al., 2009; Allard and Colaiacovo, 2010) . Nevertheless, other interpretations of the data can also be considered, like BPA having an effect through other receptors, such as ERRs, or the direct genotoxic effect of BPA, which may be, in part, involved in the effect caused by BPA on human cultured oocytes.
Human female gametogenesis starts at the early stages of fetal development and only concludes with fertilization. During this long period of time, oocytes are exposed to many chemical and physical factors. So, what are the possible implications of an increase in degenerated cells and a high number of recombination points in oocytes treated with BPA? A diminution of oocytes in the fetus could cause an alteration of ovarian reserve and quality of the oocyte in the adult female. Our results also describe an increment in the recombination points, and an alteration in the number (or localization) of the recombination pattern could affect the segregation of the homologs, leading to an increase in the possibility of generating oocytes with numerical alterations such as monosomy or trisomy (OrrWeaver et al., 1996; Bugge et al., 1998 Bugge et al., , 2007 Hassold et al., 2007; Oliver et al., 2008; Chowdhury et al., 2009; Cheng et al., 2009; Allard and Colaiacovo, 2010) .
Finally, any alterations in the number of viable oocytes as well as the quality of these oocytes could definitely have major implications for the reproductive lifespan of women, ultimately risking their reproductive capabilities. We believe that more studies should be performed to analyze the effects of BPA on the human fetal ovary and its impact on oogenesis.
